Trinity Biotech (TRIB) Accumulated Expenses (2016 - 2025)
Trinity Biotech's (TRIB) quarterly Accumulated Expenses came in at $16.9 million in Q4 2025, up 24.53% year-on-year from $13.6 million in Q4 2024, and up 24.53% quarter-over-quarter from $13.6 million in Q4 2024.
Trinity Biotech (TRIB) Accumulated Expenses (2016 - 2025) Analysis & Trends
Trinity Biotech has disclosed Accumulated Expenses across 7 years of filings, most recently posting $16.9 million for Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $16.9 million, up 24.53% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.9 million (up 24.53% YoY), and the FY2025 annual result was $16.9 million, up 24.53% from the prior year.
- Accumulated Expenses came in at $16.9 million for Q4 2025 at Trinity Biotech, up from $13.6 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $16.9 million in Q4 2025 to a low of $13.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.93 Mn |
| Dec 31, 2024 | 13.60 Mn |
| Dec 31, 2020 | 8.85 Mn |
| Dec 31, 2019 | 8.13 Mn |
| Dec 31, 2018 | 7.88 Mn |
| Dec 31, 2017 | 11.62 Mn |
| Dec 31, 2016 | 10.88 Mn |